re:inhaler overuse study

I don't think calling a 'bottom' for this SP slump is going to be easy.No apparent problems with the company and so any analysis will be speculative.
I'm prepared to make a fool of myself:the 'rollout' of product chomped the 4 mil placement;once .038 went,so chartists sold;punters reassessed timeframes;bearish suspicions scaring away people from these biotech micro-caps.
I have not employed a stop:perhaps foolish,but I really believe in the 'story' here.The volumes have been small and the market has been sickly:there is good reason to ignore present SP wobbles.

Rome wasn't build in a day.